ArticleJournal of thoracic disease2025

Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysis.

Aiben Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.